Strong patient growth across all the operating platforms

Continued investments in patient experience and clinical qualities initiatives

Successful completion of Mediclinic and Al Noor Combination and acquisition of 29.9% stake in Spire Healthcare Group

Solid financial performance with stable margins and good cash generation

Revenue growth of 7% with stable margins at 20.3% driving strong underlying earnings growth

Underlying basic earnings per share increased by 3% to 36.7 pence

Proposed final dividend per ordinary share of 5.24 pence

* IFRS measure
** Non-IFRS measure

See the reconciliations between the statutory and underlying (non-GAAP) measures.